Patients | Age (years) | Level of education (years) | Disease duration (years) | Number of HAQ-DI measurements | HAQ-DI | Patients receiving methotrexate | Patients receiving prednisone |
---|---|---|---|---|---|---|---|
Women | Â | Â | Â | Â | Â | 21.2% | 23.7% |
   Median | 57.3 | 12.0 | 8.1 | 7 | 1.25 |  |  |
   IQR | 46.8–67.0 | 12.0–14.0 | 2.4–16.7 | 4–14 | 0.63–1.88 |  |  |
Men | Â | Â | Â | Â | Â | 18.5% | 23.9% |
   Median | 61.0 | 12.0 | 7.4 | 7 | 1.00 |  |  |
   IQR | 51.4–69.0 | 11.0–14.0 | 2.0–16.6 | 3–12 | 0.25–1.50 |  |  |
All patients | Â | Â | Â | Â | Â | 20.5% | 23.8% |
   Median | 58.5 | 12.0 | 8.0 | 7 | 1.13 |  |  |
   IQR | 48.0–67.4 | 12.0–14.0 | 2.3–16.7 | 4–13 | 0.5–1.8 |  |  |